Clin2Atlas
AtlasInfectionsAcute hepatitis

Acute hepatitis C

4Curable or preventable in mostAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

Milestones

dot size = significance
199020002010202020251996 — Ritonavir approved (FDA)1997 — Interferon alfacon-1 approved (FDA)2000 — Peginterferon alfa-2b approved (FDA)2002 — Peginterferon alfa-2a approved (FDA)2008 — Eltrombopag approved (FDA)2011 — Boceprevir approved (FDA)2011 — Telaprevir approved (FDA)2013 — Simeprevir approved (FDA)2013 — Sofosbuvir approved (FDA)2014 — Daclatasvir approved (FDA)2014 — Paritaprevir approved (FDA)2014 — Ombitasvir approved (FDA)2014 — Ledipasvir approved (FDA)2014 — Dasabuvir approved (FDA)2016 — Elbasvir approved (FDA)2016 — Grazoprevir anhydrous approved (FDA)2016 — Velpatasvir approved (FDA)2017 — Voxilaprevir approved (FDA)2017 — Pibrentasvir approved (FDA)2017 — Glecaprevir approved (FDA)
1996: Drug approval — Ritonavir approved (FDA). 1997: Drug approval — Interferon alfacon-1 approved (FDA). 2000: Drug approval — Peginterferon alfa-2b approved (FDA). 2002: Drug approval — Peginterferon alfa-2a approved (FDA). 2008: Drug approval — Eltrombopag approved (FDA). 2011: Drug approval — Boceprevir approved (FDA). 2011: Drug approval — Telaprevir approved (FDA). 2013: Drug approval — Simeprevir approved (FDA). 2013: Drug approval — Sofosbuvir approved (FDA). 2014: Drug approval — Daclatasvir approved (FDA). 2014: Drug approval — Paritaprevir approved (FDA). 2014: Drug approval — Ombitasvir approved (FDA). 2014: Drug approval — Ledipasvir approved (FDA). 2014: Drug approval — Dasabuvir approved (FDA). 2016: Drug approval — Elbasvir approved (FDA). 2016: Drug approval — Grazoprevir anhydrous approved (FDA). 2016: Drug approval — Velpatasvir approved (FDA). 2017: Drug approval — Voxilaprevir approved (FDA). 2017: Drug approval — Pibrentasvir approved (FDA). 2017: Drug approval — Glecaprevir approved (FDA)

What's being tested now

2010: 1 trials started2011: 1 trials started2012: 2 trials started2013: 3 trials started2014: 1 trials started2015: 2 trials started2016: 3 trials started2017: 4 trials started2018: 2 trials started2019: 3 trials started2020: 2 trials started2021: 2 trials started2022: 7 trials started2023: 10 trials started2024: 16 trials started2025: 15 trials started2026: 17 trials started20102020202617

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

See all 81 active Hepatitis C trials on Clin2 →

Related

Acute hepatitis AAcute hepatitis BAcute hepatitis E

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.